Protein detail

DAF

Complement decay-accelerating factor (CD antigen CD55)

Entry name
DAF
UniProt ID
EVMP confidence score
0.88
Supporting publications (n)
31
Transmembrane count
Protein classification
Blood group antigen proteinsCD markersDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins
Basic Information
Protein Names
Complement decay-accelerating factor (CD antigen CD55)
Protein Class (8)
Blood group antigen proteinsCD markersDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins
Protein Function (6)
  • Predicted intracellular proteins
  • Blood group antigen proteins
  • CD markers
  • Human disease related genes:Immune system diseases:Primary immunodeficiency
  • Predicted secreted proteins
  • Disease related genes
Entrez Gene Symbol
Gene Synonym (4)
CRCROMDAFTC
Gene Description
CD55 molecule (Cromer blood group)
Chromosome
1
Position
207321519-207386804
Supporting publications (n)
31
EVMP confidence score
0.88
Fluorescence & Localization
Cell SpecificAlveolar cells type 1
Function & Pathway
Protein Function (6)
  • Predicted intracellular proteins
  • Blood group antigen proteins
  • CD markers
  • Human disease related genes:Immune system diseases:Primary immunodeficiency
  • Predicted secreted proteins
  • Disease related genes
Mediation Categories (6)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation
Relations & Evidence42

Ligand-Receptor Signaling (37)

37 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
plasma_membraneplasma_membraneUniProt_locationYesYesYes
plasma_membraneplasma_membraneCellinkerYesYesYes
plasma_membraneplasma_membraneOmniPathYesYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneMembranomeYesYesYes
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathYesYesYes
plasma_membrane_peripheralplasma_membrane_peripheralCSPAYesYesYes
plasma_membrane_peripheralplasma_membrane_peripheralOmniPathYesYesYes
secretedsecretedUniProt_keywordYesYesYes
secretedsecretedUniProt_locationYesYesYes
secretedsecretedHPA_secretomeYesYesYes
Page 3 of 4PreviousNext

Regulatory Interaction Network (1)

1 record.

Source Protein SymbolSource UniProt IDTarget Protein SymbolTarget UniProt IDIs DirectedIs StimulationIs InhibitionDatabaseReferences
DAFP08174AGRE5P48960YesYesiTALKSIGNORHINTCellPhoneDB_CellinkerHPMR_talklrHPMRCellChatDBHPRD_LRdbtalklrHPRDWangRamilowski2015HPMR_LRdbCellPhoneDBHPRD_talklrCellinkerSTRING_talklrCellTalkDBFantom5_LRdbconnectomeDB2020LRdbHINT:11297558connectomeDB2020:10540231SIGNOR:12417446Cellinker:10540231Cellinker:12417446LRdb:12417446HINT:33992645LRdb:11HPRD:10540231CellTalkDB:12417446connectomeDB2020:12417446CellChatDB:31462748HPMR:12417446

Protein Complex Composition (3)

3 records.

Component NameComponent Gene SymbolsComponent UniProt IDStoichiometryDatabaseDatabase IDsReferences
C3CD55P01024P081744:2PDBPDB:5foa
C2CD55P06681P081740:0hu.MAP2
CD55P081742PDBPDB:1ok3PDB:1ojyPDB:1ok2PDB:1ok1PDB:1ojwPDB:1ok9PDB:1h03PDB:1ojv

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass Spectrometry138037300
Sequence, Structure & Domains

Sequences

Length
381
Mass
41,400
Sequence
MTVARPSVPAALPLLGELPRLLLLVLLCLPAVWGDCGLPPDVPNAQPALEGRTSFPEDTVITYKCEESFVKIPGEKDSVICLKGSQWSDIEEFCNRSCEVPTRLNSASLKQPYITQNYFPVGTVVEYECRPGYRREPSLSPKLTCLQNLKWSTAVEFCKKKSCPNPGEIRNGQIDVPGGILFGATISFSCNTGYKLFGSTSSFCLISGSSVQWSDPLPECREIYCPAPPQIDNGIIQGERDHYGYRQSVTYACNKGFTMIGEHSIYCTVNNDEGEWSGPPPECRGKSLTSKVPPTVQKPTTVNVPTTEVSPTSQKTTTKTTTPNAQATRSTPVSRTTKHFHETTPNKGSGTTSGTTRLLSGHTCFTLTGLLGTLVTMGLLT
Alternative Products
Event=Alternative splicing; Named isoforms=7; Name=2; Synonyms=DAF-2; IsoId=P08174-1; Sequence=Displayed; Name=1; Synonyms=DAF-1; IsoId=P08174-2; Sequence=VSP_001200; Name=3; Synonyms=VDAF3; IsoId=P08174-3; Sequence=VSP_047636; Name=4; Synonyms=VDAF2; IsoId=P08174-4; Sequence=VSP_047637; Name=5; Synonyms=VDAF1; IsoId=P08174-5; Sequence=VSP_047638; Name=6; Synonyms=VDAF4; IsoId=P08174-6; Sequence=VSP_047635; Name=7; Synonyms=VDAF5; IsoId=P08174-7; Sequence=VSP_047634
Alternative Sequence
326; Q -> QGTETPSVLQKHTTENVSATRTPPTPQKPTTVNVPATIVTPTPQKPTTINVPATGVSSTPQRHTIVNVSATGTLPTLQKPTRANDSATKSPAAAQTSFISKTLSTKTPSAAQNPMMTNASATQATLTAQKFTTAKVAFTQSPSAARKSTNVHSPVTNGLKSTQRFPSAHIT (in isoform 7); 327; A -> GTETPSVLQKHTTENVSATRTPPTPQKPTTVNVPATIVTPTPQKPTTINVPATGVSSTPQRHTIVNVSATGTLPTLQKPTRANDSATKSPAAAQTSFISKTLSTKTPSAAQNPMMTNASATQATLTAQKFTTAKVAFTQSPSAAP (in isoform 6); 361..381; GHTCFTLTGLLGTLVTMGLLT -> ALQVRPFEVSGSSHISSKKMMCIL (in isoform 3); 361..381; GHTCFTLTGLLGTLVTMGLLT -> VLFM (in isoform 4); 361..381; GHTCFTLTGLLGTLVTMGLLT -> ETVFHRVIQDGLDLLASRSACLGLPKCWDYRREPPHLARAHVFHVDRFAWDASNHGLADLAKEELRRKYTQVYRLFLVS (in isoform 5); 362..381; HTCFTLTGLLGTLVTMGLLT -> SRPVTQAGMRWCDRSSLQSRTPGFKRSFHFSLPSSWYYRAHVFHVDRFAWDASNHGLADLAKEELRRKYTQVYRLFLVS (in isoform 1)

3D Structural Models

Turn
83..85; 177..180
Helix
113..115
Beta Strand
45..47; 60..65; 69..71; 78..82; 94..98; 105..109; 124..129; 133..135; 137..139; 142..145; 149..151; 157..160; 172..175; 185..190; 194..198; 200..207; 210..215; 219..222; 234..236; 241..244; 248..253; 258..261; 263..270; 273..278; 282..284
3D Structure
Electron microscopy (18); NMR spectroscopy (1); X-ray crystallography (14)

Domain & Motif Annotations

Compositional Bias
287..309; Polar residues; 310..328; Low complexity
Domain (CC)
The first Sushi domain (SCR1) is not necessary for function. SCR2 and SCR4 provide the proper conformation for the active site on SCR3 (By similarity).
Domain (FT)
35..96; Sushi 1; 96..160; Sushi 2; 161..222; Sushi 3; 223..285; Sushi 4
Region
277..354; Disordered
Protein Families
Receptors of complement activation (RCA) family
Sequence Similarities
Belongs to the receptors of complement activation (RCA) family.
Clinical Relevance
Disease Involvement
Disease variant
Biomarker
Phase 1/2; Phase 2; Discontinued in Phase 1
Drug Targets
Clinical trial target
Supporting Publications31
PMIDTitleRelated sentences
35611462Extracellular vesicles expressing CEACAM proteins in the urine of bladder cancer patients.No related sentences available
36398564Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles.No related sentences available
37786918Rapid and in-depth proteomic profiling of small extracellular vesicles for ultralow samples.No related sentences available
38168906Defining the relationship between cellular and extracellular vesicle (EV) content in breast cancer via an integrative multi-omic analysis.No related sentences available
38321535Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles.No related sentences available
39558134Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis.No related sentences available
39766158A Proteomic Examination of Plasma Extracellular Vesicles Across Colorectal Cancer Stages Uncovers Biological Insights That Potentially Improve Prognosis.No related sentences available
40089067Metabolic Reprogramming Into a Glycolysis Phenotype Induced by Extracellular Vesicles Derived From Prostate Cancer Cells.No related sentences available
40563475Unraveling the Multi-Omic Landscape of Extracellular Vesicles in Human Seminal Plasma.No related sentences available
40748658Exosomes released from senescent cells and circulatory exosomes isolated from human plasma reveal aging-associated proteomic and lipid signatures.No related sentences available
Page 3 of 4PreviousNext